Two scientists from Baskent University in Ankara, Turkey analyzed multiple substances in a cream formulation using reverse-phase high-performance liquid chromatography (RP–HPLC), according to a new study in Chromatographia (1).
For this experiment, the scientists focused on analyzing a select few substances: ruscogenin, neoruscogenin, trimebutine, and parabens, including methylparaben and propylparaben. Each of these proteins have different purposes in medicine; for example, ruscogenin is a steroid that helps in treating hemorrhoids, trimebutine is a spasmolytic agent used for treating irritable bowel syndrome (IBS), and parabens can act as endocrine system disruptors (2–4). Using a C18 column at 25°C for the separations, the mobile phase was made of acetonitrile and 20 mM phosphate buffer at pH 3.9, which was mixed in gradient elution mode using a binary pump. This method was validated and held to the requirements of the ICH Q2(R2) guideline.
The methods were deemed receptive towards all active substances and parabens. The limit of detection and limit of quantification values ranged from 0.02 to 0.45 µg mL–1 and from 0.06 to 1.35 µg mL–1, respectively. Additionally, the method’s intraday/interday accuracy (relative error ≤ 1.89) and precision (relative standard deviation ≤ 1.99) values were found in the limits, accounting for all compounds. According to validation studies, the method was found to be selective, sensitive, accurate, precise, and robust.
(1) Özen, G.; Nemutlu, E. Simultaneous Determination of Ruscogenin, Neoruscogenin, Trimebutin, and Parabens in Cream Formulation by Reverse Phase High Performance Liquid Chromatography. Chromatographia 2023, 86, 649–657. DOI: https://doi.org/10.1007/s10337-023-04282-z
(2) Ruscogenin. DrugBank. https://go.drugbank.com/drugs/DB15830 (accessed 2023-11-20)
(3) Trimebutine. DrugBank. https://go.drugbank.com/drugs/DB09089 (accessed 2023-11-20)
(4) Propylparaben. Environmental Working Group 2023. www.ewg.org/skindeep/ingredients/705335-PROPYLPARABEN/ (accessed 2023-11-20)
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.